Skip to main content
رجوع
RHCGF logo

Ryman Healthcare Limited

جودة البيانات: 100%
ذروة بيع
RHCGF
OTC Healthcare Medical - Care Facilities
KWD 1.41
KWD 0.00 (0.00%)
القيمة السوقية: 1.43B
مُدرج أيضًا باسم RYHTY OTC
نطاق اليوم
KWD 1.41 KWD 3.11
نطاق 52 أسبوعًا
KWD 1.21 KWD 3.11
حجم التداول
1
متوسط 50 يوم / 200 يوم
KWD 1.51 / KWD 1.51
الإغلاق السابق
KWD 1.41

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -3.3 0.4
P/B 0.3 2.9
ROE % -10.1 3.7
Net Margin % -61.2 3.9
Rev Growth 5Y % 12.1 10.0
D/E 0.4 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.000
KWD 0.000 – KWD 0.000
 1.4 B 0
FY2029 KWD 0.000
KWD 0.000 – KWD 0.000
 970 M 0
FY2028 KWD 0.104
KWD 0.100 – KWD 0.108
 980 M 1

النقاط الرئيسية

Revenue grew 12.08% annually over 5 years — strong growth
Earnings declined -9248.29% over the past year
Debt/Equity of 0.40 — conservative balance sheet
Generating 302.89M in free cash flow
PEG of 0.00 suggests growth is underpriced

النمو

Revenue Growth (5Y)
12.08%
Revenue (1Y)9.72%
Earnings (1Y)-9248.29%
FCF Growth (3Y)17.72%

الجودة

Return on Equity
-10.07%
ROIC-1.49%
Net Margin-61.20%
Op. Margin-16.57%

الأمان

Debt / Equity
0.40
Current Ratio0.24
Interest Coverage-0.85

التقييم

P/E Ratio
-3.28
P/B Ratio0.34
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9.72% Revenue Growth (3Y) 12.89%
Earnings Growth (1Y) -9248.29% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12.08% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 713.80M Net Income (TTM) -436.83M
ROE -10.07% ROA -3.62%
Gross Margin 100.00% Operating Margin -16.57%
Net Margin -61.20% Free Cash Flow (TTM) 302.89M
ROIC -1.49% FCF Growth (3Y) 17.72%
Safety
Debt / Equity 0.40 Current Ratio 0.24
Interest Coverage -0.85 Dividend Yield 0.00%
Valuation
P/E Ratio -3.28 P/B Ratio 0.34
P/S Ratio 2.01 PEG Ratio 0.00
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.43B Enterprise Value 3.11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 713.80M 650.53M 560.11M 503.76M 452.41M
Net Income -436.83M 4.78M 257.84M 692.87M 423.06M
EPS (Diluted) -0.61 0.01 0.50 1.31 0.80
Gross Profit 713.80M -1.35M -19.77M 1.82M 24.74M
Operating Income -118.26M -69.61M -19.77M 1.82M 24.74M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.06B 13.08B 12.51B 10.97B 9.17B
Total Liabilities 7.80B 8.67B 7.85B 7.53B 6.34B
Shareholders' Equity 4.26B 4.42B 4.66B 3.43B 2.83B
Total Debt 1.70B 2.57B 2.34B 2.59B 2.29B
Cash & Equivalents 17.66M 41.81M 27.88M 28.31M 20.17M
Current Assets 216.02M 824.61M 775.84M 741.50M 600.85M
Current Liabilities 889.82M 373.45M 255.56M 304.07M 138.11M

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#464 of 820
38

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026